NeuroPace, Inc. (NPCE)

$5.98

+0.38 (+6.79%)
Rating:
Recommendation:
-
Symbol NPCE
Price $5.98
Beta 0.000
Volume Avg. 0.06M
Market Cap 147.140M
Shares () -
52 Week Range 4.61-24.77
1y Target Est -
DCF Unlevered NPCE DCF ->
DCF Levered NPCE LDCF ->
ROE -36.57% Strong Sell
ROA -21.74% Sell
Operating Margin -
Debt / Equity 105.31% Buy
P/E -
P/B 2.31 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest NPCE news


Mr. Michael Favet
Healthcare
Medical Devices
NASDAQ Global Market

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.